AI In Mental Health Market worth US$ 10.93 Billion by 2031 – Exclusive Report by InsightAce Analytic

JERSEY CITY, N.J., Dec. 7, 2023 /PRNewswire/ — InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the “Global AI In Mental Health Market- By Application (Conversational Interfaces, Patient Behavioral Pattern Recognition), By Technology (Machine Learning and Deep Learning, Natural Language Processing (NLP), Others), By Component (Software-as-a-Service (SaaS), Hardware), Trends, Industry Competition Analysis, Revenue and Forecast To 2031.”

According to the latest research by InsightAce Analytic, the global AI In Mental Health Market is valued at US$ 0.91 Billion in 2022, and it is expected to reach US$ 10.93 Billion by 2031, with a CAGR of 31.2% during a forecast period of 2023-2031.
AI In Mental Health Market Report Scope
Report Attribute
Specifications
Market Size Value In 2022
USD 0.91 Billion
Revenue Forecast In 2031
USD 10.93 Billion
Growth Rate CAGR
CAGR of 31.2 % from 2023 to 2031
Quantitative Units
Representation of revenue in US$ Million and CAGR from 2023 to 2031
Historic Year
2019 to 2022
Forecast Year
2023-2031
Report Coverage
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends
Segments Covered
By Application, By Technology, By Component
Regional Scope
North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Country Scope
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea
Competitive Landscape
Marigold Health, Mindstrong Health, Bark Technologies, Wysa Ltd, Woebot Health, Ginger, BioBeats, Cognoa, Lyra Health, MeQuilibrium, Meru, New life solution Inc., Quartet, Spring Care Inc., Talkspace Inc. and Others
 
Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/1272
With the emergence of digital methods for mental health, current artificial intelligence (AI) (machine learning in particular) is being utilized to build mental health care solutions for prediction, detection, and therapy. Despite major advancements in digital health and the application of AI to physical health in general, the use of AI in mental health is still in its infancy. However, opportunities are emerging.
The outbreak of the COVID-19 pandemic provided a chance to demonstrate AI’s capabilities and complexity in the healthcare industry. During the pandemic’s second wave, hospitals and clinics around the world used AI-based virtual assistants, inpatient care bots, and AI-assisted surgery robots to deal with the constant influx of patients, which would have otherwise swamped the entire hospital operation cycle.
The market is being driven by a growing number of cross-industry partnerships and collaborations, as well as an increasing imbalance between the health workforce and patients, which is driving the need for improved healthcare services.
The market is also being driven by the growing demand to reduce rising healthcare costs, improving computing power and declining hardware costs, and a growing number of cross-industry partnerships and collaborations. However, several healthcare practitioners are doubtful of AI’s ability to diagnose patient ailments effectively.
Some Major Key Players in The AI In Mental Health Market:
Wysa LtdWoebot HealthGingerMarigold HealthMindstrong HealthBark TechnologiesBioBeatsCognoaLyra HealthMeQuilibriumMeruNew life solution Inc.QuartetSpring Care Inc.Talkspace Inc.OthersMarket Dynamics:
Drivers-
AI can be incorporated into digital interventions, especially online and smartphone apps, to improve user experience and improve personalized mental health care. Increased prevalence of mental disorders, growing patient base and number of people adopting mental health solutions, and increased focus of medical professionals on providing excellent treatment to patients with mental illness are anticipated to be the initial factors driving market expansion. With the use of AI mental health systems, physicians and physicists may simplify their operations. Moreover, increasing smartphone and internet penetration are driving market expansion. In addition, funding opportunities and strategic collaborations by a wide range of organizations are anticipated to fuel market expansion throughout the projection period.
Challenges:
AI has a number of uses in healthcare. However, due to data privacy issues, the industry’s use of AI is limited. In several countries, patient health data is protected by federal regulations, and any breach or failure to maintain its integrity can result in legal and financial penalties. Because AI for patient care requires access to numerous health datasets, AI-based technologies must follow all data security regulations by governments and regulatory bodies. This is a challenging process because most AI platforms are concentrated and demand a lot of computational capacity, so patient data, or parts of it, may have to be stored in a vendor’s data centre.
Regional Trends:
North America region is expected to dominate the artificial intelligence in the mental health market over the forecast period. The increasing implementation of AI technology across the continuum of care, particularly in the United States, and high healthcare spending, together with the advent of the COVID-19 pandemic, are the primary reasons driving the growth of the North American market. The increasing size and complexity of datasets driving the need for AI, rising demand to reduce rising healthcare costs, improving computing power and decreasing hardware costs, a growing number of cross-industry partnerships and collaborations, and rising imbalance between health workforce and patients driving the need for improved healthcare services are the major market drivers.
Recent Collaborations And Agreements In The Market:
In March 2022, Woebot Health announced that Leaps by Bayer, the impact investing hand of Bayer AG, made a $9.5 million strategic investment in the firm in order to expedite the development of its AI-powered behavioural health platform and solutions. Woebot Health is opening a new frontier in behavioural health at a crucial global moment by emphasizing clinical evidence and utilizing an AI-based platform and solutions.In May 2021, The Series A fundraising round for Wysa, an AI-powered mental health app, was headed by Boston-based digital health investors W Health Ventures. The company will utilize the new capital to extend its solutions for B2B clients and recruit additional personnel to meet anticipated future demand.Curious about this latest version of the report? Obtain Report Details @ https://www.insightaceanalytic.com/enquiry-before-buying/1272
Market Segments
Global AI In Mental Health Market, by Application, 2023-2031 (Value US$ Mn)
Conversational InterfacesPatient Behavioral Pattern RecognitionGlobal AI In Mental Health Market, by Technology, 2023-2031 (Value US$ Mn)
Machine Learning and Deep LearningNatural Language Processing (NLP)OthersGlobal AI In Mental Health Market, by Component, 2023-2031 (Value US$ Mn)
Software-as-a-Service (SaaS)HardwareGlobal AI In Mental Health Market, by Region, 2023-2031 (Value US$ Mn)
North AmericaEuropeAsia PacificLatin AmericaMiddle East & AfricaNorth America AI In Mental Health Market, by Country, 2023-2031 (Value US$ Mn)
U.S.CanadaEurope AI In Mental Health Market, by Country, 2023-2031 (Value US$ Mn)
GermanyUKFranceItalySpainRest of EuropeAsia Pacific AI In Mental Health Market, by Country, 2023-2031 (Value US$ Mn)
IndiaChinaJapanSouth KoreaSouth East AsiaRest of Asia PacificLatin America AI In Mental Health Market, by Country, 2023-2031 (Value US$ Mn)
BrazilArgentinaRest of Latin AmericaMiddle East & Africa AI In Mental Health Market, by Country, 2023-2031 (Value US$ Mn)
GCC CountriesSouth AfricaRest of Middle East & AfricaWhy should buy this report:
To receive a comprehensive analysis of the prospects for the global AI In Mental Health marketTo receive an industry overview and future trends of the AI In Mental Health marketTo analyze the AI In Mental Health market drivers and challengesTo get information on the AI In Mental Health market value (US$Mn) forecast to 2031Significant investments, mergers & acquisitions in the AI In Mental Health market industryFor More Information @ https://www.insightaceanalytic.com/customisation/1272
Other Related Reports Published by InsightAce Analytic:
AI-Based Clinical Trial Solution Providers Market
AI in Biopharmaceutical Development Market
AI-Enabled Drug Discovery and Clinical Trials Market
AI in Remote Patient Monitoring Market
AI in Medical Supplies/Inventory Management Market
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis of key market insights in a timely and cost-effective manner.
Contact Us:
InsightAce Analytic Pvt. Ltd.Tel.: +1 551 226 6109Email: info@insightaceanalytic.comSite Visit: www.insightaceanalytic.comFollow Us on LinkedIn @ bit.ly/2tBXsgS Follow Us On Facebook @ bit.ly/2H9jnDZ
Logo: https://mma.prnewswire.com/media/1729637/InsightAce_Analytic_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/ai-in-mental-health-market-worth-us-10-93-billion-by-2031—exclusive-report-by-insightace-analytic-302009252.html